Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib

Supplementary Data

Supplementary Data

Supplementary Data - Docx file
Supplementary Figure 1 - tif file
Supplementary Figure 2 - tif file
Supplementary Figure 3 - tif file
Supplementary Figure 4 - tif file
Supplementary Table 1 - docx file
Supplementary Table 2 - docx file
Supplementary Table 3 - docx file
Supplementary Table 4 - docx file